RECENT ADVANCES IN SELECTIVELY TARGETING PI3Kα

ADVERTISEMENT RETURN TO BOOKPREVChapterNEXTRECENT ADVANCES IN SELECTIVELY TARGETING PI3KαDavid J. St. Jean, Jr.David J. St. Jean, Jr.Scorpion Therapeutics, Boston, Massachusetts, U.S.AMore by David J. St. Jean, Jr., Trang TieuTrang TieuScorpion Therapeutics, Boston, Massachusetts, U.S.AMore by Trang Tieu, Angel Guzman-PerezAngel Guzman-PerezScorpion Therapeutics, Boston, Massachusetts, U.S.AMore by Angel Guzman-Perez, and Alexander M. TaylorAlexander M. TaylorRelay Therapeutics, Cambridge, Massachusetts, U.S.AMore by Alexander M. TaylorDOI: 10.1021/mc-2024-vol59.ch10Publication Date (Web):November 18, 2024Publication HistoryPublished online18 November 2024Request reuse permissions Copyright © 2024 MEDI, Inc. Published by American Chemical Society.2024 Medicinal Chemistry ReviewsChapter 10pp 203-224Medicinal Chemistry ReviewsVol. 59ISBN13: 9781734427493eISBN: 9781734427486Chapter Views-Citations-LEARN ABOUT THESE METRICSChapter Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts. Share ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookXWeChatLinkedInRedditEmail Other access options Get e-Alerts